Timothy F. Fidgeon’s Alnylam Pharmaceuticals ALNY Stock Holding History

Timothy F. Fidgeon’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$598K	Sell	7,443 -10	-0.1%	-$1.11K	0.3%	67
2015 Q2	$893K	Sell	7,453 -250	-3%	-$29.9K	0.4%	57
2015 Q1	$804K	Sell	7,703 -565	-7%	-$57.3K	0.35%	62
2014 Q4	$803K	Sell	8,268 -507	-6%	-$47K	0.37%	58
2014 Q3	$687K	Sell	8,775 -110	-1%	-$7.1K	0.32%	62
2014 Q2	$561K	Sell	8,885 -100	-1%	-$5.94K	0.26%	70
2014 Q1	$604K	Sell	8,985 -1,875	-17%	-$145K	0.29%	66
2013 Q4	$698K	Sell	10,860 -1,200	-10%	-$71.6K	0.33%	62
2013 Q3	$772K	Hold	12,060	–	–	0.39%	58
2013 Q2	$374K	Buy	+12,060	New	+$321K	0.2%	83

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Timothy F. Fidgeon's ALNY Position: Q3 2015 in Review

Timothy F. Fidgeon reduced its Alnylam Pharmaceuticals (ALNY) stake by 0.13% in Q3 2015, selling an estimated $1.11K and leaving 7,443 shares worth $598K. The position accounts for 0.3% of the portfolio, ranked #67.

Timothy F. Fidgeon first reported a position in ALNY in Q2 2013 and has held it in 10 quarters since. The position peaked at $893K in Q2 2015. 257 funds tracked by Wall St. Rank hold ALNY as of Q3 2015.

Timothy F. Fidgeon held 7,443 shares of Alnylam Pharmaceuticals worth $598K as of Q3 2015.
Timothy F. Fidgeon sold 10 Alnylam Pharmaceuticals shares in Q3 2015, an estimated $1.11K.
Alnylam Pharmaceuticals made up 0.3% of Timothy F. Fidgeon's portfolio in Q3 2015, its #67 holding.
Timothy F. Fidgeon first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Timothy F. Fidgeon's Alnylam Pharmaceuticals position peaked at $893K in Q2 2015.
257 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2015.

Based on Timothy F. Fidgeon's 13F filing for Q3 2015, filed 13 Nov 2015.